Harbour Investments’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Harbour Investments’s Portfolio GMVD Stock Details GMVD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20	Closed	-$8	–	3141
2023 Q2	$8	Hold	20	–	–	﹤0.01%	3016
2023 Q1	$18	Hold	20	–	–	﹤0.01%	2979
2022 Q4	$66	Sell	20 -1	-5%	-$5	﹤0.01%	2946
2022 Q3	$0	Hold	21	–	–	﹤0.01%	2878
2022 Q2	$0	Buy	+21	New	+$663	﹤0.01%	2878

Other funds holding GMVD

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Harbour Investments's GMVD Position: Q3 2023 in Review

Harbour Investments sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q3 2023, closing a stake of 20 shares — an estimated $8 sold.

Harbour Investments first reported a position in GMVD in Q2 2022 and held it in 5 quarters. The position peaked at $66 in Q4 2022. 3 funds tracked by Wall St. Rank hold GMVD as of Q3 2023.

Harbour Investments reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Harbour Investments sold 20 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q3 2023, an estimated $8.
Harbour Investments first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q2 2022 and held it in 5 quarters.
Harbour Investments's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $66 in Q4 2022.
3 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q3 2023.

Based on Harbour Investments's 13F filing for Q3 2023, filed 15 Nov 2023.